BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 20021667)

  • 1. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells.
    Farkas A; Tonel G; Nestle FO
    Br J Dermatol; 2008 May; 158(5):921-9. PubMed ID: 18371115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
    Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
    J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
    Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
    J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
    Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
    J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
    Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
    Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
    Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale.
    Kaka AS; Foster AE; Weiss HL; Rooney CM; Leen AM
    J Immunother; 2008 May; 31(4):359-69. PubMed ID: 18391760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.
    Tawab A; Fan Y; Read EJ; Kurlander RJ
    Transfusion; 2009 Mar; 49(3):536-47. PubMed ID: 19243546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
    Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
    J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
    Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
    J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E
    Yi DH; Stetter N; Jakobsen K; Jonsson R; Appel S
    Cancer Immunol Immunother; 2018 Oct; 67(10):1611-1620. PubMed ID: 30069688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
    Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
    J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E
    Gierlich P; Lex V; Technau A; Keupp A; Morper L; Glunz A; Sennholz H; Rachor J; Sauer S; Marcu A; Grigoleit GU; Wölfl M; Schlegel PG; Eyrich M
    Cancer Immunol Immunother; 2020 Jun; 69(6):1029-1042. PubMed ID: 32100075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.